Table 2.
Features | MVD | COVID-19 |
---|---|---|
Agent | Marburg virus (MARV) | SARS-CoV-2 |
Incubation period (days) | 5–10 | 4–14 (average 10) |
Transmission | Through fruit bats Contact with infected person Through body fluids of infected persons |
Respiratory droplets |
Clinical course | Progressive and severe | Mild to critical |
Signs and symptoms | Fever Malaise Headache Chills Myalgia Weight loss |
Fever, chills, malaise, body weakness Sore throat, shortness of breath, cough Headache Anosmia (loss of smell), Agusia (loss of taste) Running nose Nausea and vomiting Diarrhea |
Disease complications | Pancreatitis Liver failure Massive hemorrhage Shock Delirium Multiorgan damage |
Shock Respiratory failure Multiorgan dysfunction |
COVID-19, coronavirus disease 2019; MVD, Marburg virus disease; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.